Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study

OBJECTIVE: Intraperitoneal (IP) chemotherapy in women with optimally debulked stage III ovarian cancer has been reported to prolong overall survival, but has not been widely adopted due to concerns about its toxicity, inconvenience and acceptability to patients. The purposes of this study were to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Blinman, Prunella, Gainford, Corona, Donoghoe, Mark, Martyn, Julie, Blomfield, Penny, Grant, Peter, Kichenadasse, Ganessan, Vaughan, Michelle, Brand, Alison, Shannon, Catherine, Gebski, Val, Stockler, Martin, Friedlander, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805917/
https://www.ncbi.nlm.nih.gov/pubmed/24167672
http://dx.doi.org/10.3802/jgo.2013.24.4.359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805917/
https://www.ncbi.nlm.nih.gov/pubmed/24167672
http://dx.doi.org/10.3802/jgo.2013.24.4.359

Ejemplares similares